Neurocrine Biosciences Cash Flow from Investing Activities 2010-2025 | NBIX
Neurocrine Biosciences cash flow from investing activities for the twelve months ending March 31, 2025 was $-0.254B, a 73.38% decline year-over-year.
- Neurocrine Biosciences annual cash flow from investing activities for 2024 was $-0.127B, a 72.85% decline from 2023.
- Neurocrine Biosciences annual cash flow from investing activities for 2023 was $-0.467B, a 163.75% increase from 2022.
- Neurocrine Biosciences annual cash flow from investing activities for 2022 was $-0.177B, a 36.02% increase from 2021.